Clinical factors associated with treatment resistance in major depressive disorder: Results from a European multicenter study

Journal of Clinical Psychiatry

Volumn 68, Issue 7, 2007, Pages 1062-1070

  Souery, Daniel ^a   Oswald, Pierre ^a   Massat, Isabelle ^a   Bailer, Ursula ^d   Bollen, Joseph ^b   Demyttenaere, Koen ^c   Kasper, Siegfried ^d   Lecrubier, Yves ^e   Montgomery, Stuart ^f   Serretti, Alessandro ^g   Zohar, Joseph ^h   Mendlewicz, Julien ^a  

^a ERASME HOSPITAL   (Belgium)

^b Sint Truiden Psychiatric Center   (Belgium)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

^g SAN RAFFAELE HOSPITAL   (Italy)

^h SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; FLUOXETINE; FLUVOXAMINE; HYPERICUM PERFORATUM EXTRACT; IMIPRAMINE; MIANSERIN; MILNACIPRAN; MIRTAZAPINE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; NORTRIPTYLINE; PAROXETINE; PHENELZINE; REBOXETINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADOLESCENT; ADULT; ANXIETY DISORDER; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; ELECTROCONVULSIVE THERAPY; EUROPE; FEMALE; HAMILTON SCALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MELANCHOLIA; ONSET AGE; PANIC; PERSONALITY DISORDER; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; REMISSION; SOCIAL PHOBIA; SUICIDAL BEHAVIOR; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 34548304308     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/jcp.v68n0713     Document Type: Article

References (23)

1. Souery D, Amsterdam J, de Montigny C, et al. Treatment resistant depression: methodological overview and operational criteria. Eur Neuropsychopharmacol 1999;9:83-91
2. Fagiolini A, Kupfer DJ. Is treatment-resistant depression a unique subtype of depression? Biol Psychiatry 2003;53:640-648
3. Stimpson N. Agrawal N. Lewis G. Randomised controlled trials investigating pharmacological and psychological interventions for treatment-refractory depression: systematic review. Br J Psychiatry 2002;181:284-294
4. McPherson S, Cairns P, Carlyle J, et al. The effectiveness of psychological treatments for treatment-resistant depression: a systematic review. Acta Psychiatr Scand 2005;111:331-340
5. Thase ME, Rush AJ. When at first you don't succeed: sequential strategies for antidepressant nonresponders. J Clin Psychiatry 1997;58(suppl B):23-29
6. Fava M. Diagnosis and definition of treatment resistant depression. Biol Psychiatry 2003;53:649-659
7. The European Agency for the Evaluation of Medicinal Products. Evaluation of Medicines for Human Use. Note for Guidance on Clinical Investigation of Medicinal Products in the Treatment of Depression. London, England: European Agency for the Evaluation of Medicinal Products; April 25. 2002. CPMP/EWP/518/97, Rev. 1. Available at: http://www.emea.europa.eu/pdfs/human/ewp/ 051897en.pdf. Accessibility verified May 24, 2007
8. Petersen T, Papakostas GI, Postemak MA, et al. Empirical testing of two models for staging antidepressant treatment resistance. J Clin Psychopharmacol 2005;25:336-341
9. Nierenberg AA. Predictors of response to antidepressants: general principles and clinical implications. Psychiatr Clin North Am 2003;26:345-352
10. Krishnan KRR. Comorbidity and depression treatment. Biol Psychiatry 2003;53:701-706
11. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59(suppl 20):22-33
12. Sheehan DV, Lecrubier Y, Harnett Sheehan K, et al. The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability. Eur Psychiatry 1997;12:232-241
13. Lecrubier Y, Sheehan DV, Weiller E, et al. The Mini International Neuropsychiatric Interview (MINI): a short diagnostic structured interview: reliability and validity according to the C1DI. Eur Psychiatry 1997;12:224-231
14. Pedis RH, Miyahara S, Marangell LB, et al. Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Biol Psychiatry 2004;55:875-881
15. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62
16. Posternak MA, Zimmerman M. How accurate are patients in reporting their antidepressant treatment history? J Affect Disord 2003;75:115-124
17. Perlis RH, Ostacher MJ, Patel JK, et al. Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry 2006;163:217-224
18. Rush AJ, Fava M, Wisniewski SR, et al. Sequenced Treatment Alternatives to Relieve Depression (STAR*D): rationale and design. Control Clin Trials 2004;25:119-142
19. Fava GA, Savron G, Grandi S, et al. Cognitive-behavioral management of drug-resistant major depressive disorder. J Clin Psychiatry 1997;58:278-282
20. Flint AJ, Rifat SL. Anxious depression in elderly patients: response to antidepressant treatment. Am J Geriatr Psychiatry 1997;5:107-115
21. Sherboume C, Schoenbaum M, Wells KB, et al. Characteristics, treatment patterns, and outcomes of persistent depression despite treatment in primary care. Gen Hosp Psychiatry 2004;26:106-114
22. Khan A, Brodhead AE, Kolts RL, et al. Severity of depressive symptoms and response to antidepressants and placebo in antidepressant trials. J Psychiatr Res 2005;39:145-150
23. Emslie GJ, Mayes TL, Laptook RS, et al. Predictors of response to treatment in children and adolescents with mood disorders. Psychiatr Clin North Am 2003;26:435-156